The management of ductal carcinoma in situ is one of the most controversial areas in breast cancer management.
Henry M. Kuerer, MD, PhD, FACS
Advertisement
Articles by Henry M. Kuerer, MD, PhD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer
2
Five Under 5: Top Oncology Videos for the Week of 10/5/2026
3
GI Cancer Monthly Rewind: Key News and Expert Insights You May Have Missed in September 2026
4
FDA Grants Fast Track Designation to PSV359 for Advanced FAP-Positive Solitary Fibrous Tumors
5